Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.

导出 LinkOut

翻译打印收藏纠错

作者： Dennis Christoph,Harrer ^[1] ; Florian,Lüke ^[2] ; Tobias,Pukrop ^[3] ; Lina,Ghibelli ^[4] ; Christopher,Gerner ^[5] ; Albrecht,Reichle ^[1] ; Daniel,Heudobler ^[3]

作者单位： Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany. ^[1] Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.;Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, Regensburg, Germany. ^[2] Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.;Bavarian Cancer Research Center (BZKF), University Hospital Regensburg, Regensburg, Germany. ^[3] Department of Biology, University of Rome Tor Vergata, Rome, Italy. ^[4] Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria. ^[5]

关键词 all-trans retinoic acid anakoinosis dexamethasone interferon-α phenotypic plasticity pioglitazone transcriptional modulation tumor tissue editing

DOI 10.3389/fonc.2023.1289222

PMID 38273846

发布时间 2024-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2023年13卷

1289222页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除